{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T09:08:51Z","timestamp":1713776931916},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10165-010-0356-9","type":"journal-article","created":{"date-parts":[[2010,9,27]],"date-time":"2010-09-27T04:03:05Z","timestamp":1285560185000},"page":"43-50","source":"Crossref","is-referenced-by-count":5,"title":["Antineutrophil cytoplasmic antibodies against myeloperoxidase, proteinase 3, elastase, cathepsin G and lactoferrin in Japanese patients with rheumatoid arthritis"],"prefix":"10.1093","volume":"21","author":[{"given":"Issei","family":"Kida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeto","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinari","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,9,28]]},"reference":[{"key":"356_CR1","unstructured":"Davies DJ, Moran JE, Niall ST, Ryyan GB. Segmental necrotizing glomerulonephritis with antineutrophil antibody : possible arbovirus etiology. Br Med J (Clin Res Ed). 1982;285:606."},{"key":"356_CR2","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","volume":"318","author":"RJ Falk","year":"1988","unstructured":"Falk RJ, Jannette JC. Anti-neutrophil cytoplasmic antibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescent glomerulonephritis. N Engl J Med. 1988;318:1651\u20137.","journal-title":"N Engl J Med"},{"key":"356_CR3","unstructured":"Savage COS, Winneares CG, Jones S, Marshall PD, Loockwood CM. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm of systemic vasculitis. Lancet. 1987;1:1389\u201393."},{"key":"356_CR4","unstructured":"Van der Woude FJ, Lobatto S, Permin H, van der Giesseb M, Rasmussen N, Wiik A, et al. Antibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener\u2019s granulomatosis. Lancet 1985;1:425\u201329."},{"key":"356_CR5","first-page":"2263","volume":"78","author":"JC Jennette","year":"1990","unstructured":"Jennette JC, Hoidal JH, Falk RJ. Specificity of anti-neutrophil cytoplasmic antibodies for proteinase 3. Blood. 1990;78:2263\u20134.","journal-title":"Blood"},{"key":"356_CR6","first-page":"30","volume":"76","author":"JA Snook","year":"1989","unstructured":"Snook JA, Chapman RW, Fleming K, Jewell DP. Anti-neutrophil nuclear antibody in ulcerative colitis. Crohn\u2019s disease and primary sclerosing cholangitis. Clin Exp Immunol. 1989;76:30\u20133.","journal-title":"Clin Exp Immunol"},{"key":"356_CR7","unstructured":"Braun MG, Csernok E, Schmitt WH, Flesch BK, Gross WL. Incidence and specificity of p-ANCA in rheumatic diseases. In: Gross WL, editor. ANCA-associated vasculitis: immunological and clinical aspects. London: Plenum; 1993. p. 371\u201373."},{"key":"356_CR8","first-page":"1996","volume":"81","author":"EC Hagen","year":"1993","unstructured":"Hagen EC, Ballieux BEPB, van Es LA, Daha MR, van der Woude FJ. Antineutrophil cytoplasmic antibodies: a review of the antigens involved, assay, and the clinical and possible pathogenic consequence. Blood. 1993;81:1996\u20132002.","journal-title":"Blood"},{"key":"356_CR9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/ard.33.6.515","volume":"33","author":"A Wiik","year":"1974","unstructured":"Wiik A, Jensen E, Fries J. Granulocyte-specific antinuclear antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. Ann Rheum Dis. 1974;33:515\u201322.","journal-title":"Ann Rheum Dis"},{"key":"356_CR10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2249.1991.tb05779.x","volume":"86","author":"JA Saivge","year":"1991","unstructured":"Saivge JA, Gallichio MC, Stockman A, Cunningham TJ, Rowley MJ, Georgiou T, Davis D. Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis. Clin Exp Immunol. 1991;86:92\u20138.","journal-title":"Clin Exp Immunol"},{"key":"356_CR11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/ard.53.1.24","volume":"53","author":"G Cambridge","year":"1994","unstructured":"Cambridge G, Williams M, Leaker B, Corbett M, Smith CR. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass. Ann Rheumatic Dis. 1994;53:24\u20139.","journal-title":"Ann Rheumatic Dis"},{"key":"356_CR12","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/art.1780360805","volume":"36","author":"AHL Mulder","year":"1993","unstructured":"Mulder AHL, Horst G, van Leeuwen MA, Limburg PC, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Arthritis Rheum. 1993;36:1054\u201360.","journal-title":"Arthritis Rheum"},{"key":"356_CR13","first-page":"826","volume":"23","author":"MG Braun","year":"1996","unstructured":"Braun MG, Csernok E, Schmitt WH, Gross WL. Incidence, target antigens, and clinical implications of antineutrophil antibodies in rheumatoid arthritis. J Rheumtol. 1996;23:826\u201330.","journal-title":"J Rheumtol"},{"key":"356_CR14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/rheumatology\/35.1.38","volume":"35","author":"M Bandt De","year":"1996","unstructured":"De Bandt M, Meyer O, Haim T, Kahn M-F. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients. Br J Rheumatol. 1996;35:38\u201343.","journal-title":"Br J Rheumatol"},{"key":"356_CR15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1023\/A:1006667703202","volume":"20","author":"H Chikazawa","year":"2000","unstructured":"Chikazawa H, Nishiya K, Matsumori A, Hashimoto K. Immunoglobulin isotypes of anti-myeloperoxidase anti-lactoferrin antibodies in patients with collagen diseases. J Clin Immunol. 2000;20:279\u201386.","journal-title":"J Clin Immunol"},{"key":"356_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00296-004-0517-2","volume":"26","author":"I Manolva","year":"2005","unstructured":"Manolva I, Dantcheva M. Antineutrophil cytoplasmic antibodies in Bulgarian patients; with rheumatoid arthritis: characterization and clinical association. Rheum Int. 2005;26:107\u201314.","journal-title":"Rheum Int"},{"key":"356_CR17","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/1529-0131(200006)43:6<1371::AID-ANR22>3.0.CO;2-R","volume":"43","author":"A Mustila","year":"2000","unstructured":"Mustila A, Paimel L, Leirisalo-Repo M, Huhtala H, Huhtala H, Mietitinen A. Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis. An early maker of progressive erosion disease. Arthritis Rheum. 2000;43:1371\u20137.","journal-title":"Arthritis Rheum"},{"key":"356_CR18","unstructured":"Coremans LE, Hagen EC, Daha MR, van der Woude FJ, van der Voot EAM, Kleijburg-van der Keur C, Breedverg FC. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum. 1992;35(12):1466\u201375."},{"key":"356_CR19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/art.1780400417","volume":"40","author":"A Mustila","year":"1997","unstructured":"Mustila A, Korpela M, Mustonen J, Helin H, Huhtala H, Soppi E, Pasternak A, Mietitinen A. Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis. A marker of severe disease with associate nephropathy. Arthritis Rheum. 1997;40:710\u20137.","journal-title":"Arthritis Rheum"},{"key":"356_CR20","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2215\/CJN.01461005","volume":"1","author":"S Fujimoto","year":"2006","unstructured":"Fujimoto S, Uezono S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K, Hashimoto H, Nakao H, Nunoi H. Incidence of ANCA-associated primary renal vasculitis in the Miyazaki prefecture: the first population-based, retrospective, epidemiological survey in Japan. Clin J Am Soc Nephrol. 2006;1:1016\u201322.","journal-title":"Clin J Am Soc Nephrol"},{"key":"356_CR21","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1093\/ndt\/gfn354","volume":"23","author":"RA Watts","year":"2008","unstructured":"Watts RA, Scott DG, Jayne DR, Ito-Ihara T, Muso E, Fujimoto S, Harabuchi Y, Kobayashi S, Suzuki K, Hashimoto H. Renal vasculitis in Japan and the UK\u2014are there difference in epidemiology and clinical phenotype? Nephrol Dial Transplant. 2008;23:3928\u201331.","journal-title":"Nephrol Dial Transplant"},{"key":"356_CR22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"},{"key":"356_CR23","first-page":"268","volume":"29","author":"H Hashimoto","year":"1989","unstructured":"Hashimoto H, Abe T, Nobunaga M, Yoshizawa H, Kyogoku M, Mishima Y. Proposal of revised criteria for malignant rheumatoid arthritis. Ryumati. 1989;29:268\u201376.","journal-title":"Ryumati"},{"key":"356_CR24","first-page":"1088","volume":"23","author":"L Kotajima","year":"1996","unstructured":"Kotajima L, Aotsuka S, Sumiya M, Yokohari R, Tojo T, Kasukawa R. Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collection in a nationwide collaboration study in Japan. J Rheumatol. 1996;23:1088\u201394.","journal-title":"J Rheumatol"},{"key":"356_CR25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000441-195608000-00004","volume":"232","author":"J Lansbury","year":"1956","unstructured":"Lansbury J, Haut DD. Quantitation of the manifestations of rheumatoid arthritis 4. Area of joint surfaces as an index to total joint inflammation and deformity. Am J Med Sci. 1956;232:150\u20135.","journal-title":"Am J Med Sci"},{"key":"356_CR26","first-page":"10","volume":"23","author":"A Afeltra","year":"1996","unstructured":"Afeltra A, Sebastiani GD, Galeazzi M, Caccavo D, Ferri GM, Marcolongo R, Bonomo L. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis. J Rheumatol. 1996;23:10\u20135.","journal-title":"J Rheumatol"},{"key":"356_CR27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2249.1996.tb08294.x","volume":"103","author":"E Peen","year":"1996","unstructured":"Peen E, Sundqvist T, Skogh T. Leukocyte activation by anti-lactoferrin antibodies bound to vascular endothelium. Clin Exp Immunol. 1996;103:403\u20137.","journal-title":"Clin Exp Immunol"},{"key":"356_CR28","first-page":"176","volume":"42","author":"K Nishiya","year":"1994","unstructured":"Nishiya K, Oohara E, Oonishi N, Moriki T, Kageoka T, Sasaki M, Hashimoto K. Detection of antineutrophil cytoplasmic antibodies in sera from patients with rheumatoid arthritis by indirect immunofluorescence technique. Rinsho Byori. 1994;42:176\u201382.","journal-title":"Rinsho Byori"},{"key":"356_CR29","first-page":"2583","volume":"28","author":"N Tamura","year":"2001","unstructured":"Tamura N, Kobayashi S, Kato K, Bando H, Haruta K, Oyanagi M, Kuriyama M, Kipps TJ, Hashimoto H. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis. J Rheumatol. 2001;28:2583\u201390.","journal-title":"J Rheumatol"},{"key":"356_CR30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0167-5699(93)90210-C","volume":"14","author":"DB Jones","year":"1993","unstructured":"Jones DB, Coulson AFW, Duff GW. Sequence homology between hsp60 and autoantigens. Immumol Today. 1993;14:115\u20138.","journal-title":"Immumol Today"},{"key":"356_CR31","first-page":"1117","volume":"59","author":"N Esaguy","year":"1991","unstructured":"Esaguy N, Aguas A, van Embden JDA, Silva MT. Mycobacteria and human autoimmune disease: direct evidence of cross-reactivity between human lactoferrin and the 65-Kilodalton protein of tubercle and leprosy bacilli. Infect Immunity. 1991;59:1117\u201325.","journal-title":"Infect Immunity"},{"key":"356_CR32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1196\/annals.1422.042","volume":"1108","author":"Y Shere","year":"2007","unstructured":"Shere Y, Gerli R, Bocci EL, Gilbulg B, Vaudo G, Bistoni O, Shoenfeld Y. Heat-shock protein 65 autoantibodies are differently associated with atherosclerosis in rheumatoid arthritis and healthy subjects. Ann NY Acad Sci. 2007;1108:408\u201313.","journal-title":"Ann NY Acad Sci"},{"key":"356_CR33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/gut.38.1.135","volume":"38","author":"E Peen","year":"1996","unstructured":"Peen E, Enetr\u00f6m S, Skough T. Distribution of lactoferrin and 60\/65\u00a0kDa heatsock protein in normal and inflamed human intestine and liver. Gut. 1996;38:135\u201340.","journal-title":"Gut"},{"key":"356_CR34","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s00018-005-5366-y","volume":"62","author":"EN Baker","year":"2005","unstructured":"Baker EN. Lactoferrin A multi-tasking protein par excellence. Cell Mol Life Sci. 2005;62:2529\u201330.","journal-title":"Cell Mol Life Sci"},{"key":"356_CR35","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1007\/s00018-005-5369-8","volume":"62","author":"PP Ward","year":"2005","unstructured":"Ward PP, Paz E, Conneely OM. Multifunctional roles of lactoferrin: critical overview. Cell Mol Life Sci. 2005;62:2540\u20138.","journal-title":"Cell Mol Life Sci"},{"key":"356_CR36","unstructured":"Kaito M, Iwasa M, Fujita N, Kobayashi Y, Kojima Y, Ikoma J, Imoto I, Adachi Y, Hamano H, Yamauchi K. Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with intergeron and ribavirin. J Gastro Hepatol. 2007;22:1894\u20137."}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-010-0356-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:12Z","timestamp":1646843112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-010-0356-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,28]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1007\/s10165-010-0356-9","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,28]]}}}